SCHEMBL14356232

SCHEMBL14356232

COc1ccc2c(c1)nc([S+]([O-])Cc1ncc(C)c(OC)c1C)n2S(=O)(=O)c1c(C)cc(OCC(C)(C)C(=O)O)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.39
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
BRS3 P32247 2/20 0.35
ALDH1A1 P00352 3/20 0.34
WDR5 P61964 2/20 0.34
ATP1A1 P05023 2/20 0.34
ATP1B1 P05026 2/20 0.34
ATP1A3 P13637 2/20 0.34
ATP1B2 P14415 2/20 0.34
ATP4A P20648 2/20 0.34
HTT P42858 2/20 0.34
ATP1A2 P50993 2/20 0.34
ATP4B P51164 2/20 0.34
ATP1B3 P54709 2/20 0.34
FXYD2 P54710 2/20 0.34
ATP1A4 Q13733 2/20 0.34
KDM4E B2RXH2 1/20 0.34
DDAH1 O94760 1/20 0.34
ABCB11 O95342 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5763544 0.94 KMT2A (0.39) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL5366920 0.94 KMT2A (0.39) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL14356335 0.93 ALDH1A1 (0.32) CYP2C9ALDH1A1HTTPPARDPPARA
SCHEMBL5360440 0.93 KMT2A (0.38) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL5367198 0.93 KMT2A (0.38) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL14356228 0.90 CYP2C9 (0.41) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL5370549 0.89 CYP2C9 (0.40) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL5762457 0.89 CYP2C9 (0.40) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL5762436 0.88 CYP2C9 (0.41) CYP2C9KMT2AMEN1BRS3ALDH1A1
SCHEMBL5368303 0.88 CYP2C9 (0.36) CYP2C9KMT2AMEN1BRS3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7294716-B2 Process for preparing isomerically pure prodrugs of proton pump inhibitors ALLERGAN, INC. (US) 2007-11-13 US disclosed
US-7294716-B2 Process for preparing isomerically pure prodrugs of proton pump inhibitors ALLERGAN, INC. (US) 2007-11-13 US disclosed